BA
IONS icon

BlackRock Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

BlackRock Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.41M Buy
71,256
+7,835
+12% +$310K ﹤0.01% 1289
2016
Q3 		$2.32M Sell
63,421
-93,578
-60% -$2.93M ﹤0.01% 1401
2016
Q2 		$3.66M Sell
156,999
-971,643
-86% -$31.3M ﹤0.01% 1227
2016
Q1 		$45.7M Sell
1,128,642
-112,193
-9% -$4.56M 0.05% 331
2015
Q4 		$76.8M Buy
1,240,835
+371,437
+43% +$20M 0.08% 240
2015
Q3 		$35.1M Buy
869,398
+259,264
+42% +$13.4M 0.04% 378
2015
Q2 		$35.1M Sell
610,134
-787,481
-56% -$50.1M 0.04% 381
2015
Q1 		$89M Buy
1,397,615
+316,710
+29% +$21.5M 0.09% 231
2014
Q4 		$66.7M Buy
1,080,905
+593,166
+122% +$29.3M 0.07% 280
2014
Q3 		$18.9M Sell
487,739
-24,766
-5% -$878K 0.02% 577
2014
Q2 		$17.7M Sell
512,505
-391,380
-43% -$12.3M 0.02% 610
2014
Q1 		$39.1M Buy
903,885
+66,471
+8% +$3.22M 0.04% 402
2013
Q4 		$33.4M Sell
837,414
-490,691
-37% -$17.5M 0.03% 430
2013
Q3 		$49.9M Sell
1,328,105
-205,926
-13% -$6.15M 0.05% 333
2013
Q2 		$41.2M Buy
+1,534,031
New +$32.6M 0.04% 351

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors's IONS Position: Q4 2016 in Review

BlackRock Advisors increased its Ionis Pharmaceuticals (IONS) stake by 12% in Q4 2016, buying an estimated $310K and bringing the position to 71,256 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

BlackRock Advisors first reported a position in IONS in Q2 2013 and has held it in 15 quarters since. The position peaked at $89M in Q1 2015. 308 funds tracked by Wall St. Rank hold IONS as of Q4 2016.

  • BlackRock Advisors held 71,256 shares of Ionis Pharmaceuticals worth $3.41M as of Q4 2016.
  • BlackRock Advisors bought 7,835 Ionis Pharmaceuticals shares in Q4 2016, an estimated $310K.
  • Ionis Pharmaceuticals made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1289 holding.
  • BlackRock Advisors first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Ionis Pharmaceuticals position peaked at $89M in Q1 2015.
  • 308 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.